Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Back in April of 2017 Adam Feurnstein stated jnj has not committed to geron,we are now in April of 2018 and trials are still ongoing and jnj has listed imetelstat as blockbuster drug,so I am confused here on the committed part anyone else???
YB..... Hi guys,
He made a video about why you shouldn't trust shorties and i talked a little bit about the price history in the last 2 months.
PROOF: https://www.goodetrades.com/2017/10/eros-international-plc-eros-sues-large-number-of-short-sellers/
You can also be sure than adam fartstain is also aiding and abetting these criminals. His article was posted the morning of the Needham healthcare conference that the CEO of geron was presenting at. Then, after the conference, where we heard only good news and the price was headed back up, a bunch of law firms announced baseless investigations against geron.
Please tell me shorties what hedge fund do you think im working for and where is your proof of a hedge fund doing such illegal activities? Is your proof merely that the price went up? Pathetic.
Alpha exposure, Adam fartstain, mangrove partners and shorties on this board in particular are criminals.
Less
I think we should be proud that all of these Law Firms are coming after Geron. Think about it, would they come after the company if the company wasn't onto something big? This is a confirmation of the science and the fact that Geron has now made it onto the big boys radar. They are scared !!!!
I thing Adam Fuerstein jumped the shark and has been exposed as what he truly is, a mendacious individual who acts with criminal intent. His mistake was thinking he was only taking on Geron to help his short cabal friends, but actually, he was taking on the cadre of well respected investigators at J&J and Janssen who have done all the due diligence and stand by Geron. I hope we will see retribution for Fuernstein's malfeasance. He is simply a low life creep who actually looks the part. The science will eventually bear fruit or it will not. Trash like Fuernstein has no bearing in that process
GERN and Janssen have developed this GERN drug with the best scientist in the world. This GERN technology has won the Nobel Prize in medicine and Adam F. has a degree in politic bashing this drug technology
GERN stock holders have this.
http://www.janssen.com/oncology/leadership-team
GERN short sellers have Adam Feuerstein with a degree in politics.
To funny.Lol
Rolling on the floor. YB.
SA - leviek If Geron gets BTD for the R/R IMbark patients, will AF or AE say this is flimsy evidence? It seems it's just a matter of time. The FDA will put them in their place and what a joke to the class action lawyers as their AF article and attempt at suing Geron goes out the window.
For those of us who think the Scarlett numbers are for real, as most of us do, the FDA may have to act. Those guys are selling short but the FDA is not and all the talking in the world won't make a difference.
We're going to have to fight an uphill battle to get them off our backs but one can only make up stories to a point. The reality is JNJ is working feverishly with Imetelstat, in combos and otherwise. They don't care about all the crap that's going on around Geron. They're just doing their research.
For those of us that are in for the long run, that's all that matters. Prior to these hit articles Geron was the top biotech performer on the market year-to date. That says a lot for reality. Even today we are about 100% higher then we were on March 16th. That was 12 days ago.
In answer to one poster's comment that we should rebuttal all the naysayers, I think the group has done a great job doing that, better than I could. Anyway, I don't know about you guys but it's a lot better to just keep on finding out what's going on with Geron then trying to counteract desperate attempts to destroy what can't be destroyed. The reality will win out in the end. Even the ambulance chasers will have wasted their time.
Geron is now on everybody's radar. Any continuing good news will be reflected in spades. We have found out the power that could come from success in these trials. We also know that the trials continue to show that success. We're just going to have to get used to the volatility. It may be a precursor to the good news that may be coming.
I'll bet that many of us here didn't think a small amount of good news on survival could triple the stock price in such a short time. That news is continuing and we haven't seen any sign that it will stop in the near-term.
Imagine having a "class action" party and nobody came? YB.
Adam F. is a dirtbag, but it doesn't matter. If you're an investor, you're in this for the long haul. If Imetelstat is the real deal, which we all believe, then we will be rewarded when the JNJ buyout occurs. Consider this ridiculous dip a huge buying opportunity. Load up, and enjoy the ride to double digits.
To clarify what these roach like firms really are doing just read their bottom line, " Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP "
I say Far Q to Farugi for trying to mislead investors with advertising proclaiming alleged investigations based on the opinion of AF the shyster.
Received response from IR:
Dear xxxxx,
Thank you for your email and support.
As you know, articles and blog posts on platforms that include Seeking Alpha and others reflect the interpretations, assumptions, speculation and opinions of the authors who write them. Geron stands by its prior disclosures and does not intend to comment on such articles, whether negative or positive.
We are aware of the press releases from various law firms referencing a recent article. This is a common practice of such law firms whenever any company’s stock price drops. Our legal counsel is monitoring the situation, and we will not provide any further comments on this matter.
In the future, when mature overall survival data are available for IMbark, we expect that such data will be submitted by in full for presentation or publication in the appropriate forum, which is a medical conference or peer-reviewed scientific journal, and will then be available to investors and the public.
Best regards,
Anna
,, DOGS BARKING , BUT CARAVN GOES,,..................
Listen up, Geron "fringe lunatics". I've been invested in Geron since 2006, and there are two things you can count on each and every year. Those two things are these-- a Needham Healthcare Conference will produce, in our CEO, an inability to speak fluently and coherently, and a significant decrease in GERN's pps. I can offer no explanations for these happenings. They just happen. When they happen, there's no need for panic. JNJ pays no heed, and the scientific evidence doesn't suddenly lose credibility. The science still supports Imetelstat, and that's all that matters. Eventually, those who stay the course with Geron will profit handsomely. A smarter investor than any of us, Warren Buffett, when asked what was the best time to sell a stock, replied, "Never." The science and efficacy of Imetelstat, in relation to Geron's stock, only reinforces Buffet's belief.
YB.
Why ??? you have 5 more days cover margin call..
Bottom line is this: If you are after short-term money, GOOD LUCK this will be scary. This stock is going to be up and down like crazy with all the manipulation, etc. If you want to take a speculative, some risk always, but very derisked at this point bet that this drug will be approved, they invest with money for the long term. IMHO you will most likely be hugely rewarded starting with the J&J continuation in possibly September. No good news will be forthcoming which makes this an easy target for manipulation like you have just witnessed. After J&J says yes... this will be a moonshot. Nothing is ever a sure thing but this is one of the best possibilities I've ever seen. Why? mostly because this drug has already extended lives 3 fold and it just doesn't make sense NOT to approve it.... I've read the research and the response is VERY promising if not a downright miracle. JMO take it for what it's worth, but if you're going to let them scare you out of it, you probably shouldn't be in it..... Hold on till third quarter and you will most likely be VERY happy you did..... that's all there is to it. YB.
The results of a Mayo Clinic study demonstrate that a drug named imetelstat induces remissions in some patients with myelofibrosis. This is a form of chronic leukemia that affects the patient’s bone marrow
that is replaced by fibrosis (scar tissue) instead
of blood-producing cells.
Scientists do not yet know the exact mechanism of
action for imetelstat, but believe it interferes with the survival and proliferation of cancer cells by inhibiting
a critical enzyme called telomerase. One of the functions
of telomerase is to repair the ends of chromosomes called telomeres, and because cancer cells have shorter
than normal telomere size, they are particularly susceptible
to the drug.
The study results are promising. Some patients participating in the clinical trial taking imetelstat obtained
dramatic responses, and we have seen some complete responses (tantamount to a cure), which is almost unheard of in this disease.
STOPPING HEMATOLOGICAL CANCER:
New Drug Induces Remissions in Myelofibrosis
Although patients may experience relief in response
to other treatments, their bone marrow does not usually return to normal. But in the case of this new therapy, some of the patients participating in the trial developed normal bone marrow.
Researchers studied imetelstat in 33 patients at
Mayo Clinic and have now followed the first 22 patients for more than six months. Among these 22 patients, two achieved complete remissions and three partial remission, including reversal of bone marrow fibrosis
in four of the five patients.
http://www.mayo.edu/pmts/mc7300-mc7399/mc7323.pdf PAGE #9
empty words ..................
because the same broker unloaded warrant shares and loaded clear shares .............but you play with fire .... and will be burned . sooner or later.
, And I also see a bunch of bears trying to defend their short positions desperately. Ha ha I hope you get burned! All there short position .
Ofri - Monday 26 hours left to open Market , And I also see a bunch of bears trying to defend their short positions desperately. Ha ha I hope you get burned! All your short position ..
Why you did not sale 0,18c.? and just go...... instead complain...
normal pull back - 30- 33% from high 0.189c. People take it off profit ... Please don't listen anybody do your own DD.
Trompete - what are you doing here ? No position , you unhappy , very unhappy . Saturday !!! , people enjoyed time out with family ... try to save our money ? , but its to late . We did our own DD. Enjoy your morning . Be Blessed .
Those unhappy people , cry- investors will all time unhappy , will looking something wrong.. ,, DOGS BARKING , BUT CARAVAN GOES,, p.s. question if you in - don't cry , if you out -just go with Pease...........................
Please , don't listen this negativity , do your own DD . this tree negative brothers ,all time come in up when shares price pull back....
sorry about your short position...
look like you have see doctor ASAP ... Today you will pay full amount for your Negative , dirty speech. p.s. ,,going around, come in around,, Enjoy what you deserved....
Ofri , where are you? full over-cooked this morning , Well done..........
you can not short penny stock , at least you broker company and naked short ... liar , period.....
How’s your investment doing LIAR . you can not short penny stock , at least you broker company and naked short ... liar , period.....
Empty words , no comments..................
you are still -99.9% , we are not ..... what are you talking about?
This is looking really good that posted on the clinical trials .gov website says last submitted trial that met quality control criteria was on Jan 16th so would take that as so far good on phase III. here is the link to page https://clinicaltrials.gov/ct2/keydates/NCT02678572
New Article DCTH .... 28 December 2017 ... look how many MD - sighed... Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease......... ( After placement of the infusion catheter in the hepatic artery, a 16-F double-balloon catheter (Delcath Systems Inc, New York, NY) is inserted via the CFV and positioned with its tip in the right atrium.)
http://onlinelibrary.wiley.com/doi/10.1002/jso.24956/full
Athenex, Inc. (NASDAQ:ATNX) Insider Trades
Multiple company employees have indulged in significant insider trading. Athenex, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that EVP, Chief Medical Officer Kwan Rudolf has acquired 49,700 shares of Athenex, Inc. (ATNX) in trading session dated Jun. 19, 2017. These shares are worth $546,700 and were traded at $11 each. The SEC filing shows that Pedder Simon performed a purchase of 1,000 shares. The. added these shares by way of transaction on Jun. 19, 2017. The company’s shares were assimilated at $11 per share worth to an investment of some $11,000 on account of Pedder Simon.
clown............................
I've never seen a stock with proprietary and huge opportunities get so cleansed so many times. One would think we bottomed today or next week . It's too interesting no to own it.
look like you bag holder #1 , last Friday you got in 0.09c. don't be clown , please.
Claytrader sent 3 times DCTH board from last Friday ..... yes he shorted...
..... clown , are you little clown?
Even $9.6 Mill rev. for 2017 still double rev. from 2016 (+100% UP ) ........ PERFECTO !!! INNV - have grown revenues from $800k in 2015 to about $5 million in 2016 and now all indications are they could be at $10 million in 2017. Along with that top line revenue growth, they are showing signs of good cost-controls and during each of the last four quarters, they have reduced their undistributed operating expenses like G&A and Sales. All this is narrowing the delta between profitability and non-profitability. If the recent trend from the past four (4) Quarters holds, we will see that we are ever so close to profitability at the NOI line. I am not hypothesizing here because we have factual information that Innovus is getting close to Profitability. Innovus' Net Income in Q3 2016 was -$4.4 million; in Q4 2016 it improved to -$3.4 million; in Q1 2017 it further improved to -$2.5 million and then in Q2 2017 it was -$1.1 million, and then in Q3 2017 it was little increase - $ 1.3 million. This trend is significant and tells me that the gradual increase in revenues and a concerted effort to control expenses is yielding positive results as show in the Income Statement. p.s.NET INCOME IN : Q3 2016 was -$4.4 million to DECREASE Q3 2017 - $1.3 million ( 73% !!!!! DECREASE ). WOW !!! not bad for growing company .